Dr. Flaig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1665 Aurora Ct
Aurora, CO 80045Phone+1 720-848-0170Fax+1 720-848-0180- Is this information wrong?
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2003 - 2006
Hennepin HealthcareResidency, Internal Medicine, 1999 - 2003
University of Minnesota Medical SchoolClass of 1999
St. John's University BA, Natural Science , 1991 - 1995
Certifications & Licensure
CO State Medical License 2006 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma Start of enrollment: 2006 Jul 01
- The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease Start of enrollment: 2008 Nov 01
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPatient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pem...Milowsky, M., O'Donnell, P., Hoimes, C., Petrylak, D., Flaig, T., Moon, H., Friedlander, T., Mar, N., McKay, R., Srinivas, S., Gravis, G., Ramamurthy, C., Bupathi, M.,...> ;Journal of Clinical Oncology. 2024 Jan 12
- Use of Peripheral Intravenous Access in Patients Undergoing Chemotherapy for Testicular Cancer.Wiesen, B., Atwell, M., Leavitt, C., Clark, N., Kessler, E., Lam, E., Flaig, T., Kukreja, J., Kim, S., Maroni, P., Cost, N.> ;JCO Oncology Practice. 2024 Mar 1
- A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab.Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, Terence W Friedlander, Mehmet Asim Bilen, Shilpa Gupta, Sandy Srinivas, Jaime R Merchan, Rana R McKay, Daniel...> ;Future Oncology. 2024 Mar 1
- Join now to see all
Press Mentions
Podcast: CU Anschutz Powers up for Regenerative Medicine FrontierMay 9th, 2023- A New Way to Conduct Research: Streamlining the Clinical TrialApril 12th, 2023
- Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary IndicationsJanuary 26th, 2023
- Join now to see all
Hospital Affiliations
University of Colorado HospitalAurora, Colorado
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
